BioAgilytix

📍 Durham, United States🗓 Founded 2008👥 903 employees💰 Last funded Feb 2021
BioAgilytix is a leading global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development. With laboratory locations in North Carolina’s Research Triangle Park; Cambridge, Massachusetts; San Diego, California; Melbourne and Brisbane, Australia and Hamburg, Germany, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assay services supporting the development and release testing of therapeutics across a number of industries and disease states. BioAgilytix offers assay development, validation, and sample analysis under non-GLP, GLP, and GCP, as well as GMP quality control testing (i.e., product release testing, stability testing, etc.) BioAgilytix also offers diagnostic testing services at its CLIA-certified, CAP-accredited Boston laboratory. BioAgilytix’s team of highly experienced scientific and QA professionals ensures high-quality science, data integrity and regulatory compliance through all phases of clinical development. BioAgilytix is a trusted partner to many top global pharmaceutical and biotech companies. For more information, visit www.bioagilytix.com.
9
Total investors
1
Early stage
2
Mid stage
0
Late stage
2008
Founded
Investor geography2 countries
United States
8
United Kingdom
1
Investor activity2008–2021 · investors recorded per year
2008120132201842019120211
Recent (last 2y)Earlier
Frequently asked questions
Who invested in BioAgilytix?
BioAgilytix has 9 investors on record on gritt.io, including 1 early-stage backers, 2 mid-stage.
When did BioAgilytix last raise funding?
The most recent investment in BioAgilytix recorded on gritt.io was in February 2021.
When was BioAgilytix founded?
BioAgilytix was founded in 2008.
What industry is BioAgilytix in?
BioAgilytix operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is BioAgilytix based?
BioAgilytix is headquartered in Durham, United States.